Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Homology Medicines Inc’s current trading price is -61.58% away from its 52-week high, while its distance from the 52-week low is 9.99%. The stock’s price range during this period has varied between $0.80 and $2.29. The company, active in the Healthcare sector, saw a trading volume of around 1.31 million for the day, considerably higher average daily volume of 0.16 million observed over the last three months.
Homology Medicines Inc (FIXX) has a current stock price of $0.88. During the previous trading session, the stock witnessed a notable rise, reaching a high of $0.9762 after opening at $0.9762. The stock’s low for the day was $0.83, and it eventually closed at $1.02.
Homology Medicines Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $2.29 on 11/16/22, with the lowest value being $0.80 on 06/28/23.
How Financial Performance Impacts Market Capitalization
Homology Medicines Inc (FIXX) has experienced a quarterly decline of -19.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 50.87M and boasts a workforce of 92 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0928, with a change in price of -0.0162. Similarly, Homology Medicines Inc recorded 292,558 in trading volume during the last 100 days, posting a change of -1.81%.
How FIXX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for FIXX stands at 0.32. Similarly, the long-term debt-to-equity ratio is also 0.30.
FIXX Stock Stochastic Average
As of today, the raw stochastic average of Homology Medicines Inc over the last 50 days is at 12.17%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 19.19%. Further, the company’s Stochastic %K and %D values for the last 20 days were 34.60% and 34.40%, respectively.
FIXX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -30.17% this year. Over the last six months, there has been a stronger performance of -15.39%. The price of FIXX leaped by -15.39% during the last 30 days period. For the last 5-days stocks have slided -15.39%.